Edwards Lifesciences Stock Options Expiring on 16th of August
| EW Stock | USD 86.46 1.76 2.08% |
Edwards Lifesciences' latest option contracts expiring on 2024-08-16 are carrying combined implied volatility of 27.82 with a put-to-call open interest ratio of 0.66 over 62 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2024-08-16. The current put volume is at 16, with calls trading at the volume of 13. This yields a 1.23 put-to-call volume ratio. The Edwards Lifesciences option chain provides detailed quote and price information for the current Edwards Lifesciences Corp option contracts. It shows all of Edwards Lifesciences' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-08-16 Option Contracts
Edwards Lifesciences option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Edwards Lifesciences' lending market. For example, when Edwards Lifesciences' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Edwards Lifesciences, he or she must hedge the risk by shorting Edwards Lifesciences stock over its option's life.
2024-08-16
The chart above shows Edwards Lifesciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Edwards Lifesciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Edwards Lifesciences' option, there is no secondary market available for investors to trade.
Edwards Lifesciences Maximum Pain Price across 2024-08-16 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Edwards Lifesciences close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Edwards Lifesciences' stock options are financial instruments that give investors the right to buy or sell shares of Edwards Lifesciences Corp common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Edwards stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Edwards Lifesciences' stock price goes up or down, the stock options follow.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. Please note that buying 'in-the-money' options on Edwards Lifesciences lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Edwards Lifesciences' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Edwards Lifesciences contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Edwards Stock moves the wrong way.
At this time, Edwards Lifesciences' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 9.8 B in 2024, despite the fact that Other Stockholder Equity is likely to grow to (2.6 B). Edwards Lifesciences Corp In The Money Call Balance
When Edwards Lifesciences' strike price is surpassing the current stock price, the option contract against Edwards Lifesciences Corp stock is said to be in the money. When it comes to buying Edwards Lifesciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Edwards Lifesciences Corp are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Edwards Current Options Market Mood
Edwards Lifesciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Edwards Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Edwards Lifesciences' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Edwards Lifesciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Edwards Lifesciences' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Edwards contract
Base on the Rule 16, the options market is currently suggesting that Edwards Lifesciences Corp will have an average daily up or down price movement of about 1.74% per day over the life of the 2024-08-16 option contract. With Edwards Lifesciences trading at USD 86.46, that is roughly USD 1.5. If you think that the market is fully incorporating Edwards Lifesciences' daily price movement you should consider buying Edwards Lifesciences Corp options at the current volatility level of 27.82%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Edwards |
Edwards Lifesciences Option Chain
When Edwards Lifesciences' strike price is surpassing the current stock price, the option contract against Edwards Lifesciences Corp stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Edwards Lifesciences' option chain is a display of a range of information that helps investors for ways to trade options on Edwards. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Edwards. It also shows strike prices and maturity days for a Edwards Lifesciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-08-16 CALL at $37.5 | 0.9432 | 0.0019 | 0 | 2024-08-16 | 47.5 - 51.4 | 0.0 | In |
Call | 2024-08-16 CALL at $40.0 | 0.9379 | 0.0022 | 0 | 2024-08-16 | 45.0 - 49.0 | 0.0 | In |
Call | 2024-08-16 CALL at $42.5 | 0.9374 | 0.0024 | 0 | 2024-08-16 | 42.6 - 46.3 | 0.0 | In |
Call | 2024-08-16 CALL at $45.0 | 0.9924 | 8.0E-4 | 0 | 2024-08-16 | 40.1 - 44.2 | 0.0 | In |
Call | 2024-08-16 CALL at $47.5 | 0.9231 | 0.0032 | 0 | 2024-08-16 | 37.6 - 41.6 | 0.0 | In |
Call | 2024-08-16 CALL at $50.0 | 0.9883 | 0.0013 | 0 | 2024-08-16 | 35.2 - 39.3 | 0.0 | In |
Call | 2024-08-16 CALL at $55.0 | 0.9944 | 0.001 | 0 | 2024-08-16 | 30.3 - 34.2 | 0.0 | In |
Call | 2024-08-16 CALL at $60.0 | 0.9822 | 0.0027 | 1 | 2024-08-16 | 25.4 - 29.4 | 30.0 | In |
Call | 2024-08-16 CALL at $65.0 | 0.9176 | 0.0075 | 41 | 2024-08-16 | 20.8 - 23.2 | 13.6 | In |
Call | 2024-08-16 CALL at $67.5 | 0.9464 | 0.0074 | 23 | 2024-08-16 | 18.4 - 22.1 | 12.0 | In |
Call | 2024-08-16 CALL at $70.0 | 0.8916 | 0.0109 | 3 | 2024-08-16 | 17.1 - 19.7 | 18.7 | In |
Call | 2024-08-16 CALL at $72.5 | 0.8886 | 0.0131 | 23 | 2024-08-16 | 15.3 - 16.3 | 15.58 | In |
Call | 2024-08-16 CALL at $75.0 | 0.9658 | 0.01 | 148 | 2024-08-16 | 11.6 - 13.6 | 23.34 | In |
Call | 2024-08-16 CALL at $77.5 | 0.8234 | 0.0208 | 38 | 2024-08-16 | 9.9 - 11.5 | 11.3 | In |
Call | 2024-08-16 CALL at $80.0 | 0.8006 | 0.0277 | 231 | 2024-08-16 | 7.9 - 9.6 | 9.82 | In |
Call | 2024-08-16 CALL at $82.5 | 0.6919 | 0.0288 | 112 | 2024-08-16 | 7.6 - 7.8 | 7.0 | In |
Call | 2024-08-16 CALL at $85.0 | 0.6155 | 0.0321 | 110 | 2024-08-16 | 6.0 - 6.2 | 5.2 | In |
Call | 2024-08-16 CALL at $87.5 | 0.5324 | 0.0343 | 249 | 2024-08-16 | 4.6 - 4.8 | 4.33 | Out |
Call | 2024-08-16 CALL at $90.0 | 0.4483 | 0.0343 | 1563 | 2024-08-16 | 3.5 - 3.7 | 3.13 | Out |
Call | 2024-08-16 CALL at $92.5 | 0.3658 | 0.0331 | 220 | 2024-08-16 | 2.55 - 2.75 | 2.45 | Out |
Call | 2024-08-16 CALL at $95.0 | 0.2923 | 0.0303 | 283 | 2024-08-16 | 1.85 - 2.05 | 1.39 | Out |
Call | 2024-08-16 CALL at $97.5 | 0.2227 | 0.0268 | 290 | 2024-08-16 | 1.1 - 1.5 | 1.34 | Out |
Call | 2024-08-16 CALL at $100.0 | 0.1716 | 0.0227 | 544 | 2024-08-16 | 0.9 - 1.05 | 0.9 | Out |
Call | 2024-08-16 CALL at $110.0 | 0.057 | 0.0096 | 2600 | 2024-08-16 | 0.05 - 0.5 | 0.35 | Out |
Put | 2024-08-16 PUT at $60.0 | -0.0436 | 0.0045 | 512 | 2024-08-16 | 0.05 - 0.75 | 0.1 | Out |
Put | 2024-08-16 PUT at $65.0 | -0.0544 | 0.0065 | 23 | 2024-08-16 | 0.1 - 0.75 | 0.2 | Out |
Put | 2024-08-16 PUT at $67.5 | -0.0479 | 0.007 | 67 | 2024-08-16 | 0.25 - 0.35 | 0.5 | Out |
Put | 2024-08-16 PUT at $70.0 | -0.0694 | 0.0097 | 220 | 2024-08-16 | 0.4 - 0.5 | 0.51 | Out |
Put | 2024-08-16 PUT at $72.5 | -0.0972 | 0.0129 | 464 | 2024-08-16 | 0.6 - 0.7 | 0.75 | Out |
Put | 2024-08-16 PUT at $75.0 | -0.1338 | 0.0168 | 60 | 2024-08-16 | 0.85 - 1.0 | 1.25 | Out |
Put | 2024-08-16 PUT at $77.5 | -0.1822 | 0.0212 | 325 | 2024-08-16 | 1.25 - 1.4 | 1.5 | Out |
Put | 2024-08-16 PUT at $80.0 | -0.2427 | 0.0258 | 217 | 2024-08-16 | 1.8 - 1.95 | 2.04 | Out |
Put | 2024-08-16 PUT at $82.5 | -0.3135 | 0.0301 | 273 | 2024-08-16 | 2.5 - 2.65 | 3.03 | Out |
Put | 2024-08-16 PUT at $85.0 | -0.3954 | 0.0334 | 577 | 2024-08-16 | 3.4 - 3.6 | 3.8 | Out |
Put | 2024-08-16 PUT at $87.5 | -0.4841 | 0.0358 | 403 | 2024-08-16 | 4.5 - 4.7 | 4.6 | In |
Put | 2024-08-16 PUT at $90.0 | -0.5782 | 0.0362 | 1153 | 2024-08-16 | 5.8 - 6.1 | 6.8 | In |
Put | 2024-08-16 PUT at $92.5 | -0.6732 | 0.0342 | 535 | 2024-08-16 | 7.4 - 7.7 | 9.2 | In |
Put | 2024-08-16 PUT at $95.0 | -0.7261 | 0.029 | 231 | 2024-08-16 | 9.0 - 10.5 | 10.45 | In |
Put | 2024-08-16 PUT at $97.5 | -0.7918 | 0.0243 | 83 | 2024-08-16 | 10.8 - 12.9 | 11.6 | In |
Put | 2024-08-16 PUT at $100.0 | -0.862 | 0.0193 | 26 | 2024-08-16 | 12.2 - 15.6 | 14.0 | In |
Put | 2024-08-16 PUT at $105.0 | -0.9271 | 0.0111 | 0 | 2024-08-16 | 16.8 - 20.5 | 12.6 | In |
Put | 2024-08-16 PUT at $110.0 | -0.9351 | 0.0087 | 0 | 2024-08-16 | 21.7 - 25.6 | 26.1 | In |
Put | 2024-08-16 PUT at $115.0 | -0.9407 | 0.0071 | 0 | 2024-08-16 | 26.7 - 30.6 | 0.0 | In |
Put | 2024-08-16 PUT at $120.0 | -0.9446 | 0.006 | 0 | 2024-08-16 | 31.7 - 35.6 | 0.0 | In |
Put | 2024-08-16 PUT at $125.0 | -0.9476 | 0.0053 | 0 | 2024-08-16 | 36.7 - 40.6 | 0.0 | In |
Put | 2024-08-16 PUT at $130.0 | -0.9501 | 0.0047 | 0 | 2024-08-16 | 41.7 - 45.6 | 0.0 | In |
Put | 2024-08-16 PUT at $135.0 | -0.952 | 0.0042 | 0 | 2024-08-16 | 46.9 - 50.4 | 0.0 | In |
Put | 2024-08-16 PUT at $140.0 | -0.9536 | 0.0039 | 0 | 2024-08-16 | 51.7 - 55.6 | 0.0 | In |
Edwards Lifesciences Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Edwards Lifesciences Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Edwards Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Edwards Lifesciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Edwards Lifesciences Corporate Directors
Edwards Lifesciences corporate directors refer to members of an Edwards Lifesciences board of directors. The board of directors generally takes responsibility for the Edwards Lifesciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Edwards Lifesciences' board members must vote for the resolution. The Edwards Lifesciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Paul LaViolette | Independent Director | Profile | |
| Leslie Heisz | Independent Director | Profile | |
| Steven Loranger | Independent Director | Profile | |
| Kieran Gallahue | Independent Director | Profile |
Already Invested in Edwards Lifesciences Corp?
The danger of trading Edwards Lifesciences Corp is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Edwards Lifesciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Edwards Lifesciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Edwards Lifesciences Corp is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.036 | Earnings Share 2.32 | Revenue Per Share 10.151 | Quarterly Revenue Growth 0.095 | Return On Assets 0.1205 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.